ALT gives up premarket gains of over 20% on drug headlines earlier; shares flat
ALT gives up premarket gains of over 20% on drug headlines earlier; shares flat
ALT gives up premarket gains of over 20% on drug headlines earlier; shares flat
ALT gives up premarket gains of over 20% on drug headlines earlier; shares flat
ALT gives up premarket gains of over 20% on drug headlines earlier; shares flat